Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma

Clinical trial NCT02549833 · COMPLETED

Trial details

NCT number: NCT02549833
Sponsor: Jennie Taylor
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Oligodendroglioma Astrocytoma, Grade II Glioma, Astrocytic Glioma Malignant Glioma Oligoastrocytoma, Mixed

Start date: 2016-10-17
Primary completion: 2022-08-15
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.